Beth Smith to Neuromuscular Agents
This is a "connection" page, showing publications Beth Smith has written about Neuromuscular Agents.
Connection Strength
0.468
-
Mannava S, Mannava KA, Nazir OF, Plate JF, Smith BP, Koman LA, Tuohy CJ. Treatment of palmar hyperhidrosis with botulinum neurotoxin a. J Hand Surg Am. 2013 Feb; 38(2):398-400.
Score: 0.094
-
Stone AV, Koman LA, Callahan MF, Eckman DM, Smith BP, Plate JF, Smith TL. The effect of botulinum neurotoxin-A on blood flow in rats: a potential mechanism for treatment of Raynaud phenomenon. J Hand Surg Am. 2012 Apr; 37(4):795-802.
Score: 0.089
-
Mannava S, Plate JF, Stone AV, Smith TL, Smith BP, Koman LA, Tuohy CJ. Recent advances for the management of Raynaud phenomenon using botulinum neurotoxin A. J Hand Surg Am. 2011 Oct; 36(10):1708-10.
Score: 0.086
-
Stone AV, Ma J, Callahan MF, Smith BP, Garrett JP, Smith TL, Koman LA. Dose- and volume dependent-response to intramuscular injection of botulinum neurotoxin-A optimizes muscle force decrement in mice. J Orthop Res. 2011 Nov; 29(11):1764-70.
Score: 0.083
-
Ma J, Shen J, Smith BP, Ritting A, Smith TL, Koman LA. Bioprotection of tendon repair: adjunctive use of botulinum toxin A in Achilles tendon repair in the rat. J Bone Joint Surg Am. 2007 Oct; 89(10):2241-9.
Score: 0.065
-
Balkrishnan R, Manuel JC, Smith BP, Camacho FT, Koman LA. Longitudinal examination of health outcomes associated with botulinum toxin use in children with cerebral palsy. J Surg Orthop Adv. 2004; 13(2):76-80.
Score: 0.050